abstract |
The present invention relates to novel compounds of formula (Ia), or stereoisomeric forms thereof, mixtures of stereoisomeric forms thereof in all proportions, or physiologically acceptable salts thereof: Formula Ia In Formula Ia, Substituents are as described herein. The compounds of the present invention have CXCR5 inhibitory activity and are particularly useful for treating or preventing various inflammatory diseases associated with modulation of human CXCR5 receptors such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's disease. |